DK0892796T3 - Isatinderivater som acetylcholinesteraseinhibitorer og analgetika - Google Patents

Isatinderivater som acetylcholinesteraseinhibitorer og analgetika

Info

Publication number
DK0892796T3
DK0892796T3 DK97908942T DK97908942T DK0892796T3 DK 0892796 T3 DK0892796 T3 DK 0892796T3 DK 97908942 T DK97908942 T DK 97908942T DK 97908942 T DK97908942 T DK 97908942T DK 0892796 T3 DK0892796 T3 DK 0892796T3
Authority
DK
Denmark
Prior art keywords
analgesics
acetylcholinesterase inhibitors
isatin derivatives
isatin
derivatives
Prior art date
Application number
DK97908942T
Other languages
English (en)
Inventor
Stephen J Shimshock
Abdul E Mutlib
Susan M Chesson
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0892796T3 publication Critical patent/DK0892796T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK97908942T 1996-04-12 1997-03-07 Isatinderivater som acetylcholinesteraseinhibitorer og analgetika DK0892796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63187096A 1996-04-12 1996-04-12
PCT/US1997/003598 WO1997038993A1 (en) 1996-04-12 1997-03-07 Isatin derivatives as acetylcholinesterase inhibitors and analgesics

Publications (1)

Publication Number Publication Date
DK0892796T3 true DK0892796T3 (da) 2001-11-19

Family

ID=24533114

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97908942T DK0892796T3 (da) 1996-04-12 1997-03-07 Isatinderivater som acetylcholinesteraseinhibitorer og analgetika

Country Status (19)

Country Link
EP (1) EP0892796B1 (da)
JP (1) JP4109718B2 (da)
KR (1) KR20000005379A (da)
CN (1) CN1215399A (da)
AR (1) AR006606A1 (da)
AT (1) ATE207483T1 (da)
BR (1) BR9708655A (da)
CA (1) CA2252039C (da)
DE (1) DE69707659T2 (da)
DK (1) DK0892796T3 (da)
ES (1) ES2165586T3 (da)
GR (1) GR3037006T3 (da)
HU (1) HUP9903473A3 (da)
IL (1) IL126308A0 (da)
NO (1) NO984740L (da)
PT (1) PT892796E (da)
TW (1) TW426678B (da)
WO (1) WO1997038993A1 (da)
ZA (1) ZA972990B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
EP2536713A1 (en) 2010-02-16 2012-12-26 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CN104853755B (zh) 2012-12-13 2017-08-22 H.隆德贝克有限公司 包含沃替西汀和多奈哌齐的组合物
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US5296488A (en) * 1989-08-02 1994-03-22 Hoechst-Roussel Pharmaceuticals Inc. Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory

Also Published As

Publication number Publication date
ZA972990B (en) 1997-11-03
AU716997B2 (en) 2000-03-16
NO984740D0 (no) 1998-10-09
HUP9903473A3 (en) 2000-09-28
TW426678B (en) 2001-03-21
ATE207483T1 (de) 2001-11-15
CA2252039A1 (en) 1997-10-23
ES2165586T3 (es) 2002-03-16
JP2001508400A (ja) 2001-06-26
CA2252039C (en) 2002-12-24
AR006606A1 (es) 1999-09-08
EP0892796A1 (en) 1999-01-27
DE69707659T2 (de) 2002-05-08
GR3037006T3 (en) 2002-01-31
JP4109718B2 (ja) 2008-07-02
KR20000005379A (en) 2000-01-25
EP0892796B1 (en) 2001-10-24
DE69707659D1 (de) 2001-11-29
HUP9903473A2 (hu) 2000-05-28
BR9708655A (pt) 1999-08-03
AU2072597A (en) 1997-11-07
CN1215399A (zh) 1999-04-28
IL126308A0 (en) 1999-05-09
WO1997038993A1 (en) 1997-10-23
PT892796E (pt) 2002-03-28
NO984740L (no) 1998-10-09

Similar Documents

Publication Publication Date Title
FI956074A0 (fi) Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia
DK0892796T3 (da) Isatinderivater som acetylcholinesteraseinhibitorer og analgetika
ATE225784T1 (de) Indan- oder dihydroindolderivate
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
FI991187A0 (fi) Immunoterapeuttisia imidejä/amideja PDE IV ja TNF inhibiittoreina
NO990965D0 (no) Terapeutiske fremgangsmÕter og blandinger som inneholder isoflavoner
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO991922D0 (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
NO991676L (no) FremgangsmÕter og sammensetninger for immunmodulering
NO993217D0 (no) Br°nntetningssammensetninger og fremgangsmÕter
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
DK0900225T3 (da) Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler
PT956294E (pt) Inibidores da trombina
NO20005400D0 (no) Kinoloner anvendt som MRS-inhibitorer og baktericider
NO985621D0 (no) FremgangsmÕte og system for boring under anvendelse av skum - skumsammensetning
PT948483E (pt) Inibidores da farnesil-transferase
NO976052L (no) FremgangsmÕte og system for seriefeilvern
SI0892796T1 (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
DE59708546D1 (de) Löschgerät
UA1275S (uk) Лінійка пожежна
IS4909A (is) Spíró-píperidín afleiður og notkun þeirra sem lyfjafræðilegra miðla
KR970056749U (ko) 쇼케이스의 레일장치
FIU960594U0 (fi) Kaasusulku